S&P 500   5,056.06 (-0.11%)
DOW   37,813.03 (+0.21%)
QQQ   430.58 (-0.11%)
AAPL   169.16 (-2.04%)
MSFT   415.86 (+0.54%)
META   501.63 (+0.28%)
GOOGL   154.94 (+0.05%)
AMZN   183.64 (+0.01%)
TSLA   156.16 (-3.29%)
NVDA   875.80 (+1.84%)
AMD   163.29 (+1.85%)
NIO   3.85 (-1.03%)
BABA   69.79 (-1.18%)
T   15.98 (-1.60%)
F   12.13 (-0.82%)
MU   121.52 (+0.12%)
GE   155.59 (+1.23%)
CGC   6.85 (-1.86%)
DIS   113.79 (+0.74%)
AMC   2.80 (+13.36%)
PFE   25.75 (-0.62%)
PYPL   63.75 (+0.38%)
XOM   118.42 (-1.05%)
S&P 500   5,056.06 (-0.11%)
DOW   37,813.03 (+0.21%)
QQQ   430.58 (-0.11%)
AAPL   169.16 (-2.04%)
MSFT   415.86 (+0.54%)
META   501.63 (+0.28%)
GOOGL   154.94 (+0.05%)
AMZN   183.64 (+0.01%)
TSLA   156.16 (-3.29%)
NVDA   875.80 (+1.84%)
AMD   163.29 (+1.85%)
NIO   3.85 (-1.03%)
BABA   69.79 (-1.18%)
T   15.98 (-1.60%)
F   12.13 (-0.82%)
MU   121.52 (+0.12%)
GE   155.59 (+1.23%)
CGC   6.85 (-1.86%)
DIS   113.79 (+0.74%)
AMC   2.80 (+13.36%)
PFE   25.75 (-0.62%)
PYPL   63.75 (+0.38%)
XOM   118.42 (-1.05%)
S&P 500   5,056.06 (-0.11%)
DOW   37,813.03 (+0.21%)
QQQ   430.58 (-0.11%)
AAPL   169.16 (-2.04%)
MSFT   415.86 (+0.54%)
META   501.63 (+0.28%)
GOOGL   154.94 (+0.05%)
AMZN   183.64 (+0.01%)
TSLA   156.16 (-3.29%)
NVDA   875.80 (+1.84%)
AMD   163.29 (+1.85%)
NIO   3.85 (-1.03%)
BABA   69.79 (-1.18%)
T   15.98 (-1.60%)
F   12.13 (-0.82%)
MU   121.52 (+0.12%)
GE   155.59 (+1.23%)
CGC   6.85 (-1.86%)
DIS   113.79 (+0.74%)
AMC   2.80 (+13.36%)
PFE   25.75 (-0.62%)
PYPL   63.75 (+0.38%)
XOM   118.42 (-1.05%)
S&P 500   5,056.06 (-0.11%)
DOW   37,813.03 (+0.21%)
QQQ   430.58 (-0.11%)
AAPL   169.16 (-2.04%)
MSFT   415.86 (+0.54%)
META   501.63 (+0.28%)
GOOGL   154.94 (+0.05%)
AMZN   183.64 (+0.01%)
TSLA   156.16 (-3.29%)
NVDA   875.80 (+1.84%)
AMD   163.29 (+1.85%)
NIO   3.85 (-1.03%)
BABA   69.79 (-1.18%)
T   15.98 (-1.60%)
F   12.13 (-0.82%)
MU   121.52 (+0.12%)
GE   155.59 (+1.23%)
CGC   6.85 (-1.86%)
DIS   113.79 (+0.74%)
AMC   2.80 (+13.36%)
PFE   25.75 (-0.62%)
PYPL   63.75 (+0.38%)
XOM   118.42 (-1.05%)
NASDAQ:NXTD

Nxt-ID (NXTD) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$2.39
$4.14
52-Week Range
N/A
Volume
4,320 shs
Average Volume
1.21 million shs
Market Capitalization
$21.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NXTD stock logo

About Nxt-ID Stock (NASDAQ:NXTD)

Nxt-ID, Inc. provides technology products and services for healthcare applications that enable the Internet of Things (IoT). It operates business in one segment-hardware and software security systems and applications. The firm develops and markets solutions for payment and IoT applications. Its technology products and solutions include MobileBio, a suite of biometric solutions that secure consumers' mobile platforms, the Wocket, a next-generation smart wallet and the Flye, a digital credit card developed in collaboration with WorldVentures. The company was founded by Gino Miguel Pereira and David Charles Tunnell on February 8, 2012 and is headquartered Oxford, CT.

NXTD Stock News Headlines

A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
NEXT plc (NXT.L)
LogicMark, Inc. To Report Seco - GuruFocus.com
LogicMark, Inc. Issues Letter - GuruFocus.com
See More Headlines
Receive NXTD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nxt-ID and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/19/2019
Today
4/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Detective & Armored Car Services
Sub-Industry
N/A
Current Symbol
NASDAQ:NXTD
Fax
N/A
Employees
19
Year Founded
N/A

Profitability

Net Income
$-2,870,000.00
Pretax Margin
-68.16%

Debt

Sales & Book Value

Annual Sales
$11.44 million
Book Value
$2.03 per share

Miscellaneous

Free Float
8,649,000
Market Cap
$21.53 million
Optionable
Optionable
Beta
1.81
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Chia-Lin Simmons
    Chief Executive Officer & Director
  • Ken Hoskins
    Vice President-Operations
  • Mark J. Archer
    Chief Financial Officer
  • Bennett Porter
    Chief Marketing Officer

NXTD Stock Analysis - Frequently Asked Questions

How were Nxt-ID's earnings last quarter?

Nxt-ID, Inc. (NASDAQ:NXTD) issued its quarterly earnings results on Monday, August, 19th. The technology company reported ($1.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by $1.10. The technology company had revenue of $4.49 million for the quarter. Nxt-ID had a negative trailing twelve-month return on equity of 23.17% and a negative net margin of 68.98%.

When did Nxt-ID's stock split?

Nxt-ID shares reverse split on Monday, October 18th 2021. The 1-10 reverse split was announced on Monday, October 18th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 18th 2021. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Nxt-ID own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nxt-ID investors own include Inovio Pharmaceuticals (INO), Novavax (NVAX), Gilead Sciences (GILD), MEI Pharma (MEIP), Rigel Pharmaceuticals (RIGL), SPI Energy (SPI), TherapeuticsMD (TXMD), Allena Pharmaceuticals (ALNA) and Heat Biologics (HTBX).

This page (NASDAQ:NXTD) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners